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ABSTRACT
Multimodality imaging is indicated for the evaluation of left ventricular (LV) myocardial 
diseases. Cardiac magnetic resonance (CMR) allows morphological and functional 
assessment of the LV along with soft tissue characterization. Technological advances in 
cardiac computed tomography (CT) have led to the development of techniques for diagnostic 
acquisition in LV myocardial disease. Cardiac CT facilitates the characterization of LV 
myocardial disease based on anatomy, function, and enhancement pattern. LV regional 
and global functional parameters are evaluated using multi-phasic cine CT images. CT 
myocardial perfusion facilitates the identification of hemodynamically significant coronary 
artery stenosis. Cardiac CT with delayed enhancement is used to detect myocardial 
scarring or fibrosis in myocardial infarction and non-ischemic cardiomyopathy, and for 
the measurement of extracellular volume fraction in non-ischemic cardiomyopathy. In this 
review, we review imaging techniques and key imaging features of cardiac CT used for the 
evaluation of myocardial diseases, along with CMR findings.
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INTRODUCTION
Accurate diagnosis of left ventricular (LV) myocardial diseases is necessary to optimize 
clinical outcomes and therapeutic management.1) Imaging approaches can be challenging 
for the diagnosis of diseases affecting the LV myocardium due to considerable overlap among 
characteristic features.2) Transthoracic echocardiography is a widely utilized cardiac imaging 
modality because it is accurate, safe, low cost, does not involve ionizing radiation, and does 
not have any contraindications. However, the effectiveness of transthoracic echocardiography 
is limited by operator dependency, difficulties with soft tissue characterization, and possible 
impairment due to a poor acoustic window, large body habitus, limited field of vision, and 
technical artifacts.3) Cardiac magnetic resonance (CMR) has recently attracted increasing 
interest as the current gold standard for morphological and functional assessment of the LV, by 
allowing soft tissue characterization using different pulse sequences.4)5) However, CMR requires 
a relatively long acquisition time, higher skill levels, and has several contraindications.
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Role of Cardiac Computed 
Tomography in the Diagnosis of Left 
Ventricular Myocardial Diseases
Computed tomography (CT) has excellent spatial resolution and high temporal resolution 
of up to 66 milliseconds with short acquisition time and can be used to obtain high-quality 
multiplanar reconstructions in any desired image orientation. Emerging data have suggested 
that cardiac CT yields accurate assessments of the coronary arteries and provides anatomical 
and functional analysis of the LV cardiac chamber as well as tissue characterization of the LV 
myocardium, and is complementary to echocardiography and CMR.2)6)7) However, cardiac 
CT is not recommended as the primary method of visualization in cases of suspected LV 
myocardial disease.8) In this review, we summarize the current techniques, imaging findings, 
and role of cardiac CT imaging for LV myocardial diseases, along with CMR findings.
TECHNIQUES
State-of-the art electrocardiography (ECG)-gated cardiac CT scanning of 64 or more slices 
with 0.5 mm, 0.6 mm, or 0.625 mm collimated slice widths yields excellent isotropic 
submillimeter resolution of the heart. Wide-detector CT (256- or 320-detector-row CT 
scanner) covers the entire heart (16 cm in the z-axis direction) and yields isophasic and 
isochronic CT data without stair-step or banding artifacts. The temporal resolution ranges 
from 66 to 175 ms, depending on the scanner and reconstruction, but is still lower than 
those of CMR and echocardiography. LV regional and global functional parameters as well 
as LV myocardial anatomy are comprehensively evaluated using retrospective ECG-gated 
spiral scanning, which is based on continuous data acquisition and table movement at low 
table feed. This allows for retrospective optimization of the reconstruction window and 
image reconstruction in multiple cardiac phases. However, this technique is associated with 
relatively high radiation doses. Meanwhile, prospective ECG-triggered sequential scanning 
following the “step-and-shoot” technique uses only the selected phase of the patient's 
cardiac cycle and allows for end-systole or mid-diastole coronary assessments with low 
radiation exposure.6)9) Accordingly, prospective ECG-triggering may be inadequate for the 
interpretation of LV diameter and wall thickness. Furthermore, this method does not allow 
the evaluation of LV function (Figure 1). At present, multi-energy scanners are available 
in clinical contexts for the evaluation of myocardial pathology, and technical approaches 
to multi-energy CT include two sequential scans, rapid switching of X-ray tube potential, 
multilayer detector, and dual X-ray sources.10-12)
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Figure 1. Changes of left ventricular (LV) wall thickness during mid- and end-diastole. Evaluations of LV wall 
thickness require precise measurements, usually at end-diastole. Cardiac computed tomography is normally 
performed mid-diastole to assess the coronary artery. Interpretation of LV wall thickness with short-axis 
multiplanar reformatted images may be misleading at mid-diastole (A) compared to end-diastole (B).
There is mounting evidence favoring the clinical value of CT perfusion for the detection 
of myocardial ischemia. Myocardial perfusion can be evaluated by cardiac CT using static 
and dynamic scan acquisitions. Static CT perfusion is easily performed using any cardiac 
CT scanner and provides a snapshot of myocardial enhancement (iodine distribution) at 
one time point during the first pass of contrast material bolus (Figure 2). True perfusion 
defects persist throughout multiple phases. Static CT perfusion depends on scan timing, 
leading to poor contrast-to-tissue ratios if the peak attenuation is missed. In contrast to 
static CT perfusion, dynamic CT perfusion obtains multiple consecutive images during the 
first pass of contrast material and allows for quantitative analysis of myocardial perfusion. 
There is a wide range of myocardial blood flow cut-off values (75 to 103 mL/100mL/min) for 
distinguishing ischemic from remote myocardium. Dynamic CT perfusion imaging requires 
high temporal resolution and comprehensive LV myocardial coverage, and is associated 
with higher exposure to radiation than static perfusion CT.13-15) Ko et al.16) demonstrated that 
stress perfusion multi-energy CT combined with coronary CT angiography improves the 
performance of coronary CT angiography for the detection of hemodynamically significant 
stenosis, when compared with invasive coronary angiography combined with stress perfusion 
CMR imaging.
LV myocardial viability or scarring can be identified with delayed phase cardiac CT, which 
shares a similar pathophysiological basis with delayed enhancement CMR. A delayed phase 
CT scan is usually performed after a variable period of 5–15 min following coronary CT 
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Figure 2. Static stress perfusion cardiac computed tomography (CT) imaging in a 40-year-old male with chest 
discomfort. Short-axis multiplanar reformatted images of cardiac CT acquired at stress (A) and rest (B) show 
reversible subendocardial perfusion defects in the mid lateral, inferior, and inferoseptal left ventricular (LV) walls 
(arrowheads). Cardiovascular magnetic resonance perfusion imaging acquired at stress (C) and delayed contrast 
enhancement (D) show subendocardial myocardial infarction at the mid inferolateral and inferior LV wall (D, 
arrowheads), and peri-infarction ischemia in the mid lateral, inferior and inferoseptal LV wall (C, arrowheads). 
Stress perfusion CMR is superior to stress perfusion cardiac CT for the depiction of stress induced myocardial 
perfusion defects.
angiography with additional administration of contrast medium (Figure 3). The amount of 
contrast medium, injection rate, and time delay is tailored for each patient to evaluate the 
presence of persistent contrast due to the slow washout of iodinated contrast media from 
regions of replacement fibrosis or scarring on delayed phase cardiac CT.17) Mahnken et al.18) 
and Gerber et al.19) demonstrated that delayed phase cardiac CT can be used to quantify 
infarct size, which in turn is significantly correlated with the results of CMR-based imaging. 
The feasibility and short examination time of cardiac CT are important advantages of cardiac 
CT compared with CMR. Several studies have demonstrated that equilibrium or delayed 
phase cardiac CT allows for the measurement of myocardial extracellular volume fraction 
(ECV) and shows good agreement with ECV measured by CMR. ECV is a reproducible and 
novel index for the assessment of myocardial fibrosis, and is calculated using the following 
formula from cardiac CT: ECV = (1–hematocrit ) × (ΔHULV myocardium/ΔHULV blood), where ΔHU is 
the change in Hounsfield unit attenuation pre-contrast and in the delayed phase CT (HUdelayed 
phase – HUpre-contrast).7)20)21) Decreased tube voltage (100 or 80 kVp), multi-energy imaging, and 
increased contrast volume strengthen myocardial contrast and enhance scar or fibrosis 
visualization in delayed phase cardiac CT.
Contrast amount and injection timing are also important for the assessment of LV myocardial 
diseases, particularly LV function. A triphasic injection protocol (contrast followed by 
a saline/contrast media mixture followed by saline push) opacifies both ventricles and 
delineates the interventricular septum, allowing for the evaluation of LV wall myocardial 
anatomy and function. A rate of 5–7 mL/s is recommended for the injection of contrast 
media. Total contrast volume is usually 50-120 mL.22)
ASSESSMENT OF LV FUNCTION AND WALL THICKNESS
Accurate and reproducible measurement of LV mass and functional parameters is 
fundamental for clinical diagnosis, risk assessment, therapeutic strategy, prognosis, and 
follow-up of cardiovascular diseases.1) Echocardiography is the first non-invasive tool used 
to assess LV function. CMR is now regarded as the standard reference for the functional 
measurement of LV, affording high accuracy and reproducibility. The quantification of LV 
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Figure 3. Infarct imaging using arterial and delayed-enhancement cardiac computed tomography (CT) in a 
patient with an old myocardial infarction in the left circumflex territory. Short-axis multiplanar reformatted (MPR) 
images of arterial (A) and delayed-phase (B) cardiac CT show thinned myocardium with fixed subendocardial 
perfusion defect (arrowheads) and delayed transmural hyperenhancement (arrow) in the mid inferior left 
ventricular wall. (C) Curved MPR coronary CT angiography image shows significant stenosis with noncalcified 
plaque of the left main coronary artery (arrow) and occlusion at the distal left circumflex artery (arrowhead). 
Subendocardial perfusion defect indicates microvascular occlusion.
function using cardiac CT has been validated in many prior studies via comparisons with 
echocardiography and CMR.23) Excellent correlation and linear relations were seen between 
cardiac CT and CMR for assessments of LV end-diastolic and end-systolic volume, LV stroke 
volume, LV ejection fraction, and LV mass. Bak et al.24) demonstrated that dual-source CT 
based on a threshold-based technique yielded highly reproducible measurements of global LV 
parameters, which were significantly smaller than the CMR values obtained using Simpson's 
method except for the ejection fraction.
Knowledge of the normal range of LV wall thickness is important to diagnose several 
common cardiac diseases that are characterized by hypertrophy or abnormal wall thinning. 
In Korean adults without any prior history of cardiac disease, LV myocardial thickness 
(septal wall thickness, 1.08 ± 0.18 cm vs. 0.90 ± 0.17 cm; posterior wall thickness, 0.91 ± 
0.15 cm vs. 0.78 ± 0.10 cm; relative wall thickness, 0.38 ± 0.08 cm vs. 0.33 ± 0.05 cm), LV 
volume (end-diastolic volume, 112.9 ± 26.1 mL vs. 98.2 ± 21.0 mL; end-systolic volume, 41.7 
± 14.7 mL vs. 33.7 ± 12.2 mL), and LV mass (145.0 ± 29.1 g vs. 107.9 ± 20.0 g) obtained with 
320-detector-row CT were significantly greater (p < 0.01) in men than in women. However, 
these significant differences disappeared after being normalized for body surface area.25) 
In other words, the mean LV myocardial thickness measured on cardiac CT was less than 
11 mm at the septum and 10 mm at the posterior wall. The reference range of LV septal and 
posterior wall thickness at end-diastole using echocardiography is 0.6-1.0 cm in males and 
0.6-0.9 cm in females. For any LV segment observed on short-axis CMR images, the average 
minimum/maximum myocardial thickness was 4/11 mm in males and 4/9 mm in females. 
LV hypertrophy (LVH) is usually defined by interventricular septal and/or posterior wall 
thickness in end-diastole > 11 mm.26)
Cardiac CT provides not only anatomical but also functional information about the LV 
myocardium, particularly in patients with myocardial infarction (MI) and cardiomyopathies 
(Figure 4). Measurement of LV functional parameters by cardiac CT is particularly useful in 
cases of equivocal or suboptimal echocardiography or contraindications for CMR such as 
pacemakers and defibrillators. However, routine measurements of LV functional parameters 
using cardiac CT cannot be recommended for all patients because they require contrast 
media and radiation exposure.8) The value of cardiac CT as a first-choice assessment tool for 
LV structure and function can only be assessed through additional research.
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Figure 4. Global and regional left ventricular (LV) function assessment with cardiac computed tomography (CT) in an 80-year-old woman with ischemic 
cardiomyopathy. Four-chamber multiplanar reformatted (MPR) images of cardiac CT obtained during end-diastole (A) and end-systole (B) show dilated LV 
cavity and apical ballooning with thinned apical lateral wall and akinesia/dyskinesia (arrows, apical aneurysm). The mid inferior and mid inferolateral LV walls 
(arrowheads) are noted to be thin and akinetic on short-axis MPR image of cardiac CT obtained at the end-systolic phase (C). LV ejection fraction, end-diastolic, 
and end-systolic volumes were 31%, 198 mL, and 137 mL, respectively. Conventional coronary angiography confirmed total occlusion at the proximal right 
coronary artery and subtotal occlusion at the mid anterior descending coronary artery and distal left circumflex coronary artery (not shown).
MYOCARDIAL INFARCTION AND TRUE AND FALSE LV 
ANEURYSMS
Myocardial infarction
MI is the leading cause of death and a main cause of morbidity in developed countries.27) 
The most typical cause of MI is acute intracoronary thrombosis superimposed on 
unstable atherosclerotic plaque. The infarct progresses like a “wavefront pattern” from 
the endocardium toward the epicardium.28) Ischemic cardiomyopathy is defined as LV 
systolic dysfunction with one or more of the following criteria: history of prior myocardial 
revascularization or MI, more than 75% stenosis in the left main stem or proximal left 
anterior descending artery, or 2 or more epicardial coronary arteries on invasive or CT 
coronary angiography.29)
Non-contrast or precontrast cardiac CT helps to detect fatty replacement (lipomatous 
metaplasia) or calcification of the LV myocardium in coronary artery territory, which is 
indicative of old MI (Figure 5). The prevalence of LV myocardial fat is 22%–62% among 
patients with a history of MI. Myocardial fat associated with healed MI appears as an 
area of linear or curvilinear subendocardial low attenuation in the culprit coronary 
artery.30-32) Ichikawa et al.32) demonstrated that LV myocardial fat was mostly located in 
the subendocardium (94%) of the region perfused by the infarct-related artery and was 
commonly present in patients with infarct age ≥ 3 years (89%). Infarcted myocardial areas are 
hypoattenuated due to the reduced distribution of contrast medium during the first passage 
on arterial phase cardiac CT. Focal wall thinning, regional LV wall motion abnormality, LV 
remodeling, LV thrombus, and aneurysm can be easily diagnosed on early phase cardiac 
CT.33)34) End-diastolic wall thickness in thinned regions < 6 mm is defined as irreversible 
myocardial damage (nonviable myocardium) and obviates the need for viability testing.35) 
Nieman et al.36) demonstrated that the difference in CT attenuation between infarcted and 
remote normal myocardia was significantly greater in patients with old MI than in patients 
with acute MI (89 ± 41 and 55 ± 33 HU, respectively, p < 0.001). In addition, LV wall thinning 
and ventricular dilation are only associated with old MI.
Delayed phase cardiac CT facilitates the accurate estimation of infarct size and microvascular 
occlusion in acute MI.37) Sato et al.38) showed that when myocardial contrast displayed 
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Figure 5. Left ventricular (LV) myocardial fat with cardiac computed tomography (CT) in a 51-year-old male with 
old myocardial infarction. (A) A curved multiplanar reformatted coronary CT angiography image shows significant 
stenosis (arrowhead) of the proximal left anterior descending coronary artery. Precontrast (B) and arterial phase 
(C) cardiac CT images show curvilinear fat deposition (arrowheads) in the subendocardium of the thinned LV 
myocardium (6 mm in thickness) in apical septal and lateral LV wall.
delayed enhancement size on delayed phase cardiac CT obtained immediately after primary 
percutaneous coronary intervention, it could help predict clinical outcomes in patients with 
acute MI.
LV aneurysm and pseudoaneurysm
Clinical distinction between true and pseudoaneurysms remains a challenge, but it is 
important to guide proper management. LV aneurysm describes a saccular protrusion 
containing the full thickness of the thinned LV wall with scarred myocardium that balloons 
outward, and akinesia or dyskinesia. Transmural MI is the major underlying cause of LV 
aneurysm, and usually involves the apical, anterior, or anterolateral wall. Cardiac CT and 
MR imaging findings include a wide mouth, smooth transition from normal myocardium to 
thinned, scarred myocardium with delayed enhancement, and akinesia or dyskinesia during 
systole (Figure 6). Fatty replacement or calcification of the infarcted myocardial wall and 
thrombus formation may be present. Surgical repair (aneurysmectomy) is recommended for 
cases refractory to medical treatment for dysrhythmias, angina, systemic embolization, or 
heart failure.39)40)
LV pseudoaneurysm results from rupture of the LV free wall, contained by an overlying 
adherent pericardium or scar tissue. Pseudoaneurysm is more commonly seen in inferior and 
lateral wall segments attributed to MI following left circumflex coronary artery occlusion.41) 
Unlike the wide mouth of a true aneurysm, the mouth of a pseudoaneurysm is narrower than 
the diameter of the aneurysm. Other imaging findings include abrupt transition from normal 
myocardium to aneurysm, a distinct discontinuity of the ventricular wall, and dyskinesia 
during both systole and diastole (Figure 7). Pseudoaneurysms have poor prognoses because 
of the high risk of expansion and rupture, leading to cardiac tamponade, shock, and death. 
Therefore, they call for urgent surgical repair. CMR facilitates the differentiation between 
LV pseudoaneurysms and true aneurysms via tissue characterization, viability imaging, and 
detection of wall motion abnormalities. High isotropic spatial resolution cardiac CT imaging 
allows for visualization of all planes of the heart and thus reveals segments that are difficult 
to see on echocardiography, providing diagnostic clues for differentiating LV aneurysm and 
pseudoaneurysm.40)42)
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Figure 6. Left ventricular (LV) aneurysm with calcification and intracavitary thrombus in a 65-year-old male with 
old myocardial infarction (MI). Axial delayed-phase cardiac computed tomography image obtained at the end-
systolic phase shows an LV apical aneurysm with calcification (arrow), intracavitary thrombus (arrowheads), and 
delayed transmural hyperenhancement of the apical to mid septal LV myocardium (thin arrows). Four-chamber 
delayed-phase cardiac magnetic resonance image obtained at the mid-diastolic phase shows an apical aneurysm 
with intracavitary thrombus (arrowheads) and diffuse subendocardial delayed hyperenhancement of the LV 
septum and lateral wall (arrows), consistent with old MI.
CARDIOMYOPATHY AND MYOCARDITIS
Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is the most common genetic heart disease and 
exhibits autosomal dominant inheritance. The classical diagnosis of HCM is based on 
unexplained diffuse or segmental LVH without compensatory dilation of the LV chamber, 
and with normal or supernormal systolic function demonstrated by imaging techniques. 
Heart failure, arrhythmias, ischemia, and sudden death represent major complications of 
HCM.43-45) The diagnostic criterion for HCM is a LV wall thickness of ≥ 15 mm (measured at 
end-diastole) in at least one LV myocardial segment. Maximum LV wall thickness ≥ 30 mm is 
associated with sudden cardiac death.46) Most patients with HCM have an asymmetric septal 
hypertrophy, which is defined as hypertrophy with a septal-to-inferolateral wall thickness 
ratio ≥ 1.3 in normotensive heart patients (≥ 1.5 in hypertensive patients) (Figure 8). Other 
various types of HCM are concentric, mid-ventricular, apical, mass-like, and reverse-curve. 
End-stage (burnout or dilated phase) HCM is present in 2.4% to 15.7% of individuals and is 
characterized by wall thinning, LV dilation, and systolic dysfunction (Figure 9). Myocardial 
fibrosis with delayed enhancement CMR images can be focal (patchy or massive mid-wall 
enhancement) and located near the right ventricular insertion points, or diffuse.4)47-49)
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Figure 7. Left ventricular (LV) pseudoaneurysm with calcification and intracavitary thrombus in a 65-year-old 
male with stable angina. Short-axis multiplanar reformatted (A) and thick slap maximum intensity projection (B) 
images of cardiac computed tomography obtained at the end-diastolic phase show LV inferior wall outpouching 
with a relatively narrow neck (black arrow), intracavitary thrombus, and multiple calcifications along its wall 
(arrowheads).
A B C
Figure 8. Asymmetrical septal hypertrophic cardiomyopathy in a 57-year-old man with chest pain. (A) Short-axis multiplanar reformatted (MPR) image of arterial 
phase cardiac computed tomography (CT) shows asymmetrical hypertrophy of the mid anterior, septal, and inferior left ventricular (LV) wall at end-diastole. 
Short-axis MPR images of delayed phase cardiac CT (B) and cardiac magnetic resonance (C) show diffuse transmural enhancement in the septum, anterior, and 
inferior LV wall (arrowheads).
Recently, Lee et al.21) demonstrated that mean ECV values for patients with HCM (32.31% 
± 0.97%) were significantly higher (p < 0.01) than in healthy subjects (26.32% ± 0.90%) on 
dual-energy equilibrium or delayed phase cardiac CT. Cardiac CT allows for the evaluation 
of HCM based on key morphological characteristics (presence, location, distribution, and 
severity of LVH), LV systolic function, the mitral valve and its apparatus, intraventricular 
obstruction, extent of myocardial fibrosis with delayed enhancement and ECV measurement 
(tissue characterization), and the presence of LV crypts. These indicators are used alongside 
anatomical imaging of the coronary arteries (stenosis, myocardial bridging), particularly 
when echocardiographic images are suboptimal and CMR is contraindicated.4)49)50)
Sarcoidosis
Cardiac sarcoidosis is a rare multisystemic disorder of unknown cause that is characterized 
by the presence of noncaseous epithelioid granulomas. Clinical manifestations of cardiac 
sarcoidosis range from lack of symptoms to sudden cardiac death or advanced heart 
failure. Although granulomas and/or fibrous scars can be distributed anywhere in the 
myocardium, transmural distribution is most common and nontransmural lesions are 
often subepicardial or midmyocardial. The active phase of cardiac sarcoidosis results 
in focal myocardial thickening. In the chronic phase, sarcoid lesions ultimately heal 
through myocardial fibrosis, which results in myocardial thinning, regional wall motion 
abnormalities, and ventricular aneurysm. Delayed enhancement CMR suggesting the 
diagnosis of cardiac sarcoidosis is characterized by multifocal involvement and involvement 
of the basal anteroseptum and inferoseptum, which demonstrates contiguous extension 
into the right ventricle. However, the distribution and changes of myocardial thickness with 
delayed enhancement patterns mimic other cardiomyopathies.51-53) Cardiac CT demonstrates 
global or regional hypokinesia, focal wall thickening (acute), focal thinning and ventricular 
aneurysm (chronic), diverse delayed enhancement pattern (transmural, subepicardial, 
or midmyocardial), and increase in myocardial ECV in cardiac sarcoidosis as well as the 
involvement of other organs (Figure 10).21)50)54)
Amyloidosis
Cardiac amyloidosis is characterized by abnormal deposition of pathological and insoluble 
amyloid proteins within the myocardial extracellular space. The majority of cardiac 
amyloidosis cases are caused by one of two proteins, either light chains or transthyretin. 
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Figure 9. End-stage midventricular hypertrophic cardiomyopathy in a 76-year-old female. Four-chamber 
multiplanar reformatted arterial (A) and delayed-phase (B) cardiac computed tomography images show 
hypertrophy involving the middle third of the left ventricle (LV) (A, arrows) along with apical thinning, resulting 
in the characteristic hourglass or dumbbell-shaped appearance of the LV cavity, transmural apical enhancement 
(B, arrows), and hypoenhancing foci along the subendocardial surface in this region (A and B, arrowhead), 
compatible with thrombus.
Approximately 50% of patients with light-chain amyloidosis develop cardiac involvement. 
The prognosis for cardiac amyloidosis is poor and associated with subtype and degree of 
amyloid infiltration. LVH with biatrial dilation, preserved systolic function, and restrictive 
diastolic filling pattern are pathognomonic imaging findings of cardiac amyloidosis. Delayed 
enhancement CMR shows circumferential subendocardial delayed enhancement that is 
most pronounced at the middle to basal LV wall in 80% of patients with cardiac amyloidosis. 
The pattern of delayed myocardial enhancement is more specific than the morphologic 
and functional findings.55)56) Arterial phase cardiac CT demonstrates LV wall thickening 
with subtle lower attenuation. Circumferential subendocardial or transmural delayed 
enhancement is apparent in delayed phase cardiac CT (Figure 11).54)57) Recent studies have 
demonstrated that the mean ECV value in patients with amyloidosis was higher than that in 
patients with severe aortic stenosis (AS) (54% ± 11% vs. 28% ± 4%, p < 0.001) and healthy 
subjects (53.45% ± 1.19% vs. 26.32% ± 0.90%, p < 0.01).7)21) Accordingly, cardiac CT can 
provide non-invasive diagnosis and quantification of cardiac amyloidosis.
Dilated cardiomyopathy
Dilated cardiomyopathy (DCM) is the most common type of non-ischemic cardiomyopathy 
and represents an end-stage manifestation of multiple non-ischemic cardiomyopathies. 
DCM is characterized by LV dilation and contractile dysfunction in the absence of CAD, 
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Figure 10. Cardiac sarcoidosis in a 61-year-old female with irregular cardiac rhythm and dyspnea. (A) Short-axis multiplanar reformatted image of cardiac 
computed tomography (CT) was used to obtain the arterial phase, which shows asymmetrically hypertrophied mid septum and inferior left ventricular (LV) 
wall (arrowheads) at end-diastole. Delayed-phase cardiac CT (B) and cardiovascular magnetic resonance (C) images diffuse midwall and transmural delayed 
enhancement (arrowheads) in the entire LV wall.
A B
Figure 11. Cardiac amyloidosis in a 74-year-old male who presented with chest pain. Two-chamber multiplanar 
reformatted image of arterial (A) and delayed-phase cardiac computed tomography (B) obtained during mid-
diastole shows hypertrophy of the left ventricular (LV) myocardial wall and diffuse, concentric subendocardial 
and transmural enhancement (arrowheads) in the LV myocardial wall.
pressure overload, and infiltrative cardiomyopathies. Sudden cardiac death may be the first 
manifestation of idiopathic DCM. Mortality increases with arrhythmia, progressive heart failure, 
and thromboembolism.58) LV dilation and LV global systolic dysfunction without regional 
wall motion abnormalities are characteristic imaging findings of DCM, and are occasionally 
associated with right ventricular dilation and hypertrabeculation of both ventricles (Figure 12). 
The LV walls are usually thin, but may be normal or even thickened. Mural thrombi may be 
present in the LV and occasionally in the atria. Three types of DCM-related delayed enhancement 
include: midwall, subendocardial, or transmural delayed enhancement. Linear or bandlike 
midwall delayed enhancement of the interventricular septum is present in approximately 30% of 
patients with DCM, and this feature differentiates DCM from ischemic cardiomyopathy. Absence 
of delayed enhancement has also been reported (59%). DCM is also associated with myocardial 
fat deposition in 18%–24% of cases.59)60) Cardiac CT shows  LV global systolic dysfunction, 
dilated ventricle, LV wall thinning (diastolic wall thickness < 5.5 mm), linear midwall delayed 
enhancement, midwall fat, and absence of significant CAD, allowing for differentiation of DCM 
patients from those with ischemic cardiomyopathy.26)50)54) In addition, delayed CT demonstrates 
expansion of ECV in patients with DCM compared with healthy subjects (31.25% ± 0.79% vs. 
26.32% ± 0.90%, p < 0.01).21)
Non-compaction cardiomyopathy
Non-compaction cardiomyopathy (NCC) is characterized by extensive LV trabeculation 
and deep intertrabecular recesses. Clinical manifestations are highly variable, ranging 
from absence of symptoms to LV systolic dysfunction, heart failure, arrhythmias, 
systemic thromboembolism, and sudden cardiac death.61) NCC is primarily diagnosed by 
echocardiography and CMR imaging findings consistent with increased thickness of the 
noncompacted layer (higher proportion of noncompacted myocardium) compared with the 
compacted layer.62)63) The most frequently involved segments include the apical and mid-
ventricular areas of the inferior and lateral walls of the LV.
CMR imaging results showing a ratio of LV noncompacted myocardium to compacted 
myocardium > 2.3 at end-diastole, LV dilation, and LV global hypokinesia are diagnostic 
hallmarks of NCC. Cardiac CT allows for clear depiction of trabeculations along the LV wall 
and precise measurement of the end-diastolic thickness of noncompacted and compacted 
myocardium and areas of trabecular and subendocardial delayed enhancement (Figure 13).64) 
Melendez-Ramirez et al.65) showed that a noncompacted to compacted myocardial thickness 
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Figure 12. Dilated cardiomyopathy in a 63-year-old male. Short-axis multiplanar reformatted images of arterial-phase cardiac computed tomography obtained 
during end-diastole (A) and end-systole (B) show a dilated left ventricle (LV), preserved myocardial thickness, and severe global hypokinesia. (C) Delayed-phase 
four-chamber cardiovascular magnetic resonance imaging shows dilated left cardiac chambers and subtle midwall delayed enhancement (arrowhead). LV 
ejection fraction, end-diastolic, and end-systolic volumes were 14.7%, 341 mL, and 291 mL, respectively.
ratio ≥ 2.2 in ≥ 2 segments indicated a diagnosis of NCC. Additional cardiac CT findings may 
include LV systolic dysfunction and LV thrombus.
Myocarditis
Myocarditis is an acute or chronic inflammatory disease of the myocardium and is an 
important underlying etiology of other myocardial diseases. The clinical presentation of 
acute myocarditis is heterogeneous (ranging from asymptomatic to sudden cardiac death) 
and coronary angiography is often required to exclude acute coronary syndrome. Myocarditis 
is characterized by direct cardiomyocyte injury, accompanied by edema, necrosis, and 
regional or global contractile dysfunction.66-69)
CMR shows multiple patchy or nodular areas of high T2 signal intensity and delayed 
enhancement, predominantly in the sub-epicardial and inferolateral portions of the LV. The 
extent of delayed enhancement is gradually decreased on follow-up. In the chronic phase, the 
remaining delayed enhancement lesions reflect the late post-inflammatory fibrotic phase, 
featuring scar formation and irreversible damage to the LV wall, as well as LV dilation.70)71) 
In patients with acute chest pain and elevated cardiac biomarkers, cardiac CT may facilitate 
the differentiation of myocarditis and acute coronary syndrome via characteristic midwall 
or subepicardial delayed enhancement and the absence of significant CAD during the same 
examination (Figure 14). Bouleti et al.72) demonstrated that multi-energy delayed phase 
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Figure 13. Non-compaction cardiomyopathy in a 33-year-old female with acute pain. Short-axis multiplanar 
reformatted images of arterial phase cardiac computed tomography obtained during end-diastole show 
increased thickness of the noncompacted layer in the anterior, lateral, and inferior segments of the mid left 
ventricular wall, with a ratio of noncompacted (black arrow) to compacted myocardium (white line) > 2.3:1.
Figure 14. Myocarditis in a 25-year-old male who had complained of dyspnea for 10 days. Short-axis multiplanar 
reformatted image of delayed-phase cardiac computed tomography shows midwall delayed enhancement in the mid 
anteroseptum (arrow) and subepicardial enhancement in the lateral and anterior left ventricular wall (arrowheads).
cardiac CT showed 95% diagnostic accuracy for detecting inflammatory segments (delayed 
iodine enhancement) compared with delayed enhancement CMR in 20 patients with acute 
myocarditis. In addition, cardiac CT may be used to demonstrate global or regional LV wall 
motion abnormalities.73) Accordingly, cardiac CT is a promising substitute for CMR and 
conventional coronary angiography in patients with suspected acute myocarditis.
LV HYPERTROPHY RELATED TO INCREASED AFTERLOAD
Hypertension
Hypertension is highly prevalent and remains one of the most relevant cardiovascular risk 
factors. The high mortality rates of hypertension patients are related to LVH. Echocardiographic 
signs of LVH are seen in 20%-40% of patients with hypertension. Hypertensive hearts usually 
show concentric LVH and interventricular septal thickness increases of up to 15 mm (Figure 
15). Left atrial dilation is also seen in hypertension.74)75) Diffuse myocardial fibrosis is frequently 
seen but poorly evaluated with delayed enhancement CMR. Rodrigues et al.76) demonstrated 
asymmetric hypertrophy of the mid to basal septum (asymmetric end-diastolic wall thickness 
of ≥ 15 mm and > 1.5-fold the opposing myocardial segment in ≥ 1 segments) in 21% of a purely 
hypertensive cohort. Asymmetric hypertensive heart disease overlaps morphologically with 
HCM based on the end-diastolic wall thickness threshold of 15 mm advocated by the European 
HCM guidelines. Cardiac CT allows measurements of LV mass, volume, and wall thickness, and 
excludes CAD in patients with hypertension. However, issues regarding the use of radiation and 
nephrotoxic iodinated contrast remain.
Aortic stenosis
AS is the most frequent type of valvular heart disease (VHD) in the elderly, and is increasing 
in prevalence.77) The main causes of AS are age-related: degenerative calcified AS of tricuspid 
aortic valve, a congenital bicuspid aortic valve, and rheumatic VHD. AS increases LV afterload 
and causes compensatory LVH. LVH leads to reversible myocardial ischemia and irreversible 
myocardial injury, such as interstitial myocardial fibrosis.78) Therefore, AS is a disease of both 
the aortic valve and LV myocardium. Usually, the LV wall is symmetrically hypertrophied 
in AS, and occasionally an area of the LV shows a nonuniform pattern of hypertrophy 
(asymmetrical septal hypertrophy).79) Dweck et al.80) demonstrated that the pattern of 
LV adaptation and degree of hypertrophy were not correlated with the severity of valve 
narrowing. Asymmetric patterns of wall thickening were common (27%) in patients with 
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Figure 15. Hypertensive heart disease in a 72-year-old male. Short-axis and four-chamber multiplanar 
reformatted early-phase cardiac computed tomography images obtained during end-diastole show a 
concentrically hypertrophied entire left ventricular wall.
moderate-to-severe AS. Several studies have shown that focal myocardial fibrosis appears as 
a diverse pattern of midwall delayed enhancements on delayed enhancement CMR images in 
patients with severe AS (Figure 16).80-82)
Cardiac CT is an important imaging modality in severe AS patients who are indicated for 
surgical valve replacement or transcatheter aortic valve replacement, because it provides 
detailed anatomic information about the aortic valve, coronary artery, ascending thoracic 
aorta, and LV.83) Recently, Song et al.84) showed that aortic valve calcium volume score on cardiac 
CT was associated with severity of myocardial fibrosis in severe AS patients. Bandula et al.20) 
showed that there was a significant correlation between both equilibrium cardiac CT - and 
equilibrium CMR imaging-derived ECV and percentage of histologic fibrosis (r = 0.71, p < 0.001 
and r = 0.84, p < 0.0001, respectively). Accordingly, delayed phase cardiac CT has potential to 
assess myocardial fibrosis with delayed enhancement pattern and ECV measurement. However, 
the role of myocardial fibrosis imaging by cardiac CT is not established in clinical practice.
SIGMOID SEPTUM
Sigmoid septum is characterized by isolated basal septal hypertrophy (> 14 mm in thickness 
or basal-septal wall thickness ≥ 2 mm thicker than the mid-septal wall thickness) and 
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Figure 16. Severe aortic valve stenosis in a 79-year-old man with chest discomfort and shortness of breath. (A) 
Double oblique multiplanar reformatted (MPR) image of aortic valve shows thickened and calcified cusps of 
the bicuspid aortic valve (arrowheads) with a severely reduced opening (aortic valve area of 82 mm2) during 
early systole. (B) Short-axis MPR image shows the hypertrophied mid left ventricular (LV) wall, and particularly 
asymmetric septal hypertrophy (arrowheads). Delayed-phase cardiac computed tomography (CT) (C) and 
cardiovascular magnetic resonance (CMR) (D) images show delayed subendocardial hyperenhancement in the 
lateral and inferior LV wall (arrowheads). Diffuse midwall delayed enhancement in the LV septum (arrows) is 
only identified on delayed-enhancement CMR. Delayed enhancement CMR is superior to delayed-enhancement 
cardiac CT for the depiction of patterns of delayed myocardial enhancement.
the absence of septal abnormalities, with normal wall thickness elsewhere in older 
normal subjects. However, the condition is more prevalent in elderly subjects with higher 
systolic blood pressures (Figure 17).85)86) Sigmoid septum is associated with increased 
angulation between the aorta and LV cavity and is mainly caused by pressure overload 
from hypertension.87) Sigmoid septum in patients with hypertension is a very early sign of 
hypertensive heart disease, indicating LV remodeling with increasing regional wall thickness 
and reduced local myocardial function.85) Cardiac CT provides anatomical information about 
the LV wall, particularly the basal-to-mid interventricular septum, with delayed contrast 
enhancement on 3-chamber and short-axis multiplanar reformatted images.
CONCLUSIONS
Multiple imaging modalities are required for detailed and comprehensive evaluations of 
patients with LV myocardial disease. Echocardiography and CMR are indispensable tools 
in the diagnosis of LV myocardial diseases. Rapid advances in CT techniques with high 
temporal and spatial resolution facilitate the assessment of LV myocardial pathology beyond 
coronary artery evaluation. Cardiac CT has yielded promising results for the detection and 
characterization of LV myocardial diseases in several ways, particularly for the evaluation 
of coronary arteries, quantification of LV function, elucidation of detailed morphological 
characteristics, and myocardial perfusion and scar imaging. These data may be collected all 
at one sitting. In particular, single- and multi-energy delayed phase cardiac CT can be used 
for assessing cases of diffuse myocardial fibrosis such as CMR and under-diagnosed and 
treatable causes of LVH and heart failure, particularly in patients with contraindications to 
CMR imaging.7)20)21) Even though cardiac CT is not recommended as the primary method of 
choice in cases of suspected LV myocardial disease, it may be useful in specific situations 
when echocardiography or CMR are not suitable.
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